Twist Bioscience to Present at JSNN NanoImpacts 2022

Rhea-AI Summary

Twist Bioscience Corporation (NASDAQ: TWST) announced that Steffen Hellmold, SVP of Business Development for Data Storage, will present at the JSNN NanoImpacts 2022 conference from October 13-15, 2022 in Greensboro, NC. He will participate in a panel on October 13 and deliver a keynote on DNA data storage on October 14 at 9:00 AM ET. The conference aims to address advancements in synthetic biology and nanomaterials, following the 2018 SemiSynBio Roadmap.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present at the Joint School of Nanoscience and Nanoengineering (JSNN) NanoImpacts 2022: Semiconductor Synthetic Biology and Beyond taking place October 13-15, 2022 in Greensboro, NC.

Mr. Hellmold will participate in the panel “Perspectives on SemiSynBio: Progress to Date; What’s Missing? And What’s Next?” on Thursday, October 13 at 2:10 PM ET. He will give a keynote speech on Friday, October 14 at 9:00 AM ET on progress being made towards delivering DNA data storage at scale.

The NanoImpacts 2022 Conference highlights progress being made towards achieving goals laid out in the 2018 SemiSynBio Roadmap (SSBR), refines the vision for future initiatives and explores potential synthetic biology and nanomaterial processes and application opportunities beyond the scope of the SSBR.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005222/en/

For Twist Bioscience:

Angela Bitting

SVP, Corporate Affairs

925- 202-6211

abitting@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

When is the JSNN NanoImpacts 2022 conference where TWST will present?

The JSNN NanoImpacts 2022 conference will take place from October 13-15, 2022.

Who from TWST will present at the NanoImpacts 2022 conference?

Steffen Hellmold, SVP of Business Development for Data Storage, will represent TWST.

What is the topic of Steffen Hellmold's keynote speech at the conference?

His keynote speech will focus on progress in delivering DNA data storage at scale.

What are the key dates for Steffen Hellmold's presentation at the conference?

He will participate in a panel on October 13 and present the keynote on October 14.

What is the focus of the NanoImpacts 2022 conference?

The conference will address advancements in synthetic biology and nanomaterials in line with the 2018 SemiSynBio Roadmap.